Literature DB >> 19654533

Practice patterns in the management of fungal corneal ulcers.

Allison R Loh1, Kevin Hong, Salena Lee, Mark Mannis, Nisha R Acharya.   

Abstract

PURPOSE: The purpose of this study was to determine the practice patterns of ophthalmologists in the management of fungal corneal ulcers.
METHODS: In December 2007, a survey of 13 questions addressing the actual and preferred treatment of fungal ulcers was sent to the kera-net e-mail listserv facilitated by the Cornea Society.
RESULTS: Ninety-two respondents from North America, South America, Asia, Europe, and Australia participated by completing the electronic questionnaire. Natamycin was the most commonly used topical treatment for ulcers caused by filamentous fungi (96%) followed by amphotericin (75%) and voriconazole (63%). However, voriconazole was most often listed as the preferred topical treatment in an ideal world (79%) compared with 55% for natamycin. Approximately half of the respondents use combination topical therapy (56%) and the remainder monotherapy. The majority of respondents rescrape the epithelium at some time during the course of treatment, but the frequency of rescraping varied among the different topical treatments. The most common reasons cited for not using their preferred treatment were cost and a desire for further evidence to support preferred treatment.
CONCLUSION: There appears to be significant variation in the management of fungal corneal ulcers. Although natamycin was the most commonly used treatment for ulcers caused by filamentous fungi, voriconazole was the most preferred as the ideal treatment. These results highlight the need for more evidence regarding the efficacy of the newer topical antifungals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654533     DOI: 10.1097/ICO.0b013e318199fa77

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  26 in total

1.  Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.

Authors:  Prajna Lalitha; Brett L Shapiro; Allison R Loh; Annette W Fothergill; N Venkatesh Prajna; M Srinivasan; Catherine E Oldenburg; David A Quigley; Jaya D Chidambaram; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

2.  Natamycin and Azithromycin Are Synergistic In Vitro against Ocular Pathogenic Aspergillus flavus Species Complex and Fusarium solani Species Complex Isolates.

Authors:  Haoyi Guo; Lutan Zhou; Yi He; Chuanwen Gao; Lei Han; Yan Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 3.  Current state of in vivo confocal microscopy in management of microbial keratitis.

Authors:  Radhika L Kumar; Andrea Cruzat; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

4.  Cell penetrating peptides as efficient nanocarriers for delivery of antifungal compound, natamycin for the treatment of fungal keratitis.

Authors:  Aastha Jain; Sushmita G Shah; Archana Chugh
Journal:  Pharm Res       Date:  2014-12-03       Impact factor: 4.200

5.  Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.

Authors:  Aileen Sy; Stephen D McLeod; Elisabeth J Cohen; Todd P Margolis; Mark J Mannis; Thomas M Lietman; Nisha R Acharya
Journal:  Cornea       Date:  2012-07       Impact factor: 2.651

6.  Contact lens-related polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida albicans.

Authors:  Maria Luiza Carneiro Buchele; Débora Borgert Wopereis; Fabiana Casara; Jefferson Peres de Macedo; Marilise Brittes Rott; Fabíola Branco Filippin Monteiro; Maria Luiza Bazzo; Fernando Dos Reis Spada; Jairo Ivo Dos Santos; Karin Silva Caumo
Journal:  Parasitol Res       Date:  2018-08-10       Impact factor: 2.289

7.  Evolution of Practice Patterns for the Treatment of Fungal Keratitis.

Authors:  Catherine E Oldenburg; N Venkatesh Prajna; Abdou Amza; Allison Loh; Nisha R Acharya; Mark J Mannis; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

8.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

9.  The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.

Authors:  N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Lalitha Prajna; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kathryn J Ray; Michael E Zegans; Stephen D McLeod; Travis C Porco; Nisha R Acharya; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

10.  Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.

Authors:  Catherine Q Sun; N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Kieran S O'Brien; Kathryn J Ray; Stephen D McLeod; Travis C Porco; Nisha R Acharya; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-14       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.